FOX Translator
No data currently available.
No data currently available.
Even if you don't think you do, you already know plenty about commodities. Want us to prove it? No problem.
What makes oil produced in Saudi Arabia different from oil exported from Nigeria? It's the same thing that makes the corn you ate at last summer¿s barbecue different from the corn used to produce ethanol. Stumped? Well, don't feel bad, it's a trick question. The answer? Absolutely nothing. Corn is corn no matter where it comes from -- just as wheat is wheat and natural gas is -- right! -- natural gas. (Though the quality may differ, the make-up is uniform.)
So, in less elaborate terms, corn and oil (and all other commodities) are homogenous goods that can be processed, resold and more often than not, used as an input to the production of other goods or services. These goods are traded on a commodity exchange, thus setting the price-per-barrel (or other metric unit) used to value them.
Now pay attention, here's a question that indeed does have an answer: What is the difference between a commodity and a stock? While a stock can tank and become worthless, a commodity cannot have its value be wiped to zero. One other difference: Most commodities are traded in futures, meaning traders buy and sell where they think the price of a product will be at a certain point in the future. Stocks trade based on the value of the underlying company at that point in time.
Home / Markets / Industries / Health Care
Friday, July 04, 2008
eResearch Issues Update Report on Victhom Human Bionics Inc.
Comtex
TORONTO, ONTARIO, Jul 04, 2008 (MARKET WIRE via COMTEX) ----Victhom Human Bionics Inc. specializes in the development of artificial intelligence-based prosthetics and fully implantable neuro-stimulation devices for the treatment of stroke-related physical dysfunctions.
As a medical device company, Victhom focuses on the research, development and commercialization of bionic devices that target physical dysfunctions caused by limb amputation, and disorders such as foot drop, sleep apnea, and chronic pain. Areas of specialty include the Orthotics and Prosthetics and neuro-modulation markets. The Company has a portfolio of 50 granted and 75 pending patents in various countries worldwide.
Victhom is currently focusing on two products: Neurostep and POWER KNEE 2. Plans to commercialize the Neurostep in 2009 mean that a partnership agreement may be on the horizon. The POWER KNEE 2 is attracting greater market attention and expanding addressable market size.
We have increased our one-year Target Price to $0.40 per share from $0.30, with our valuation based on discounted cash flow and sales multiple analyses. We continue to rate the shares as a Speculative Buy, suitable for risk-tolerant investors willing to take a longer-term view.
This Press Release was prepared by eResearch and was not vetted by Victhom Human Bionics Inc. Further, the Recommendation and Target Prices contained in this Press Release and in the Initiating Report are strictly those of eResearch and, due to securities laws, are not endorsed by Victhom Human Bionics Inc.
eResearch is a primary source for professional investment research, focused primarily on small- and mid-cap companies. Our research and analysis is of institutional quality, and has the potential of reaching millions of global investors through our extensive electronic distribution network.
Victhom Human Bionics Inc. paid eResearch a fee of $18,500 + GST to conduct research on the Company, on an Annual Continuous Coverage basis.
For FREE access to all eResearch reports and articles, go to www.eresearch.ca.
Contacts: eResearch Bob Weir, CFA Director of Research (416) 643-7643 Email: bweir@eresearch.ca Website: www.eresearch.ca
SOURCE: eResearch
mailto:bweir@eresearch.ca http://www.eresearch.ca
Copyright 2008 Market Wire, All rights reserved.
Market Snapshot
| Symbol | Last Price | Netchange | Volume |
|---|---|---|---|
| -- | -- | -- | -- |
| -- | -- | -- | -- |
| -- | -- | -- | -- |
| -- | -- | -- | -- |
| -- | -- | -- | -- |
FOX Business Tools
Sponsored By
